David J. Evans
Impact in
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 25
-
- Vibrio bacteria research studies 19
- Co-authors
- Suzanne M. J. FleiszigAhmed H. KissebahR K KalkhoffPeter AdamsROBERT MURRAYN. VydelingumD K PetersC M Lockwood
- Journals
- The Lancet (14 papers)Infection and Immunity (14 papers)Investigative Ophthalmology & Visual Science (13 papers)Histopathology (7 papers)Journal of Clinical Pathology (7 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
David J. Evans
239 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Nephrology 1.3k
- Molecular Medicine 791
- Endocrinology 671
- Ophthalmology 1.0k
- Physiology 3.0k
Countries citing papers authored by David J. Evans
This map shows the geographic impact of David J. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Evans more than expected).
Fields of papers citing papers by David J. Evans
This network shows the impact of papers produced by David J. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Evans. The network helps show where David J. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside David J. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 26 | |
| 6 | 2016 | 7 | |
| 7 | Subversion of inflammasomes and pyroptosis in human corneal epithelial cells by Pseudomonas aeruginosa | 2015 | 1 |
| 8 | Efficacy and Structure-Activity of Keratin-Derived Antimicrobial Peptides (kDAMPs): A Novel Role for Intermediate Filament Proteins in Corneal Innate Defense | 2012 | 1 |
| 9 | 2010 | 30 | |
| 10 | 2005 | 62 | |
| 11 | Twitching Motility Contributes to the Role of Pili in Corneal Infection Caused by Pseudomonas aeruginosa | 2003 | 5 |
| 12 | 1997 | 44 | |
| 13 | 1996 | 255 | |
| 14 | 1995 | 264 | |
| 15 | 1985 | 18 | |
| 16 | Defibrination with ancrod in experimental chronic immune complex nephritis | 1975 | 18 |
| 17 | 1974 | 5 | |
| 18 | 1973 | 113 | |
| 19 | 1968 | 6 | |
| 20 | 1966 | 0 |
About David J. Evans
David J. Evans is a scholar working on Molecular Medicine, Endocrinology, Nephrology, Immunology and Allergy and Ophthalmology, having authored 249 papers that have together received 13.0k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (50 papers), Ocular Surface and Contact Lens (40 papers), Ocular Infections and Treatments (27 papers), Antibiotic Resistance in Bacteria (25 papers), Renal Diseases and Glomerulopathies (23 papers), Vasculitis and related conditions (23 papers), Vibrio bacteria research studies (19 papers) and Cell Adhesion Molecules Research (16 papers). The work is most often cited by research in Nephrology (1.3k citations), Molecular Medicine (791 citations), Endocrinology (671 citations), Ophthalmology (1.0k citations) and Physiology (3.0k citations). David J. Evans has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Suzanne M. J. Fleiszig, Ahmed H. Kissebah, R K Kalkhoff, Peter Adams, ROBERT MURRAY, N. Vydelingum, D K Peters, C M Lockwood, Peter J. Barnes and Andrew J. Rees. Their work appears in journals such as The Lancet, Infection and Immunity, Investigative Ophthalmology & Visual Science, Histopathology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.